BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11812244)

  • 1. Kinetic mechanism of allosteric regulation of muscle glycogen phosphorylase B by adenosine 5'-monophosphate.
    Klinov SV; Kurganov BI
    Biochemistry (Mosc); 2001 Dec; 66(12):1374-7. PubMed ID: 11812244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined kinetic mechanism describing activation and inhibition of muscle glycogen phosphorylase b by adenosine 5'-monophosphate.
    Klinov SV; Kurganov BI
    Biophys Chem; 2001 Aug; 92(1-2):89-102. PubMed ID: 11527582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic mechanism of activation of muscle glycogen phosphorylase b by adenosine 5'-monophosphate.
    Klinov SV; Kurganov BI
    Arch Biochem Biophys; 1994 Jul; 312(1):14-21. PubMed ID: 8031120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Delayed activation of muscle glycogen phosphorylase b on incubation of the enzyme with adenosine-5'-monophosphate].
    Kurganov BI; Shchors EI; Chebotareva NA; Klinov SV
    Biokhimiia; 1995 Jan; 60(1):88-104. PubMed ID: 7696433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism for regulating the activity of muscle glycogen phosphorylase b by adenosine-5'-monophosphate].
    Klinov SV; Kurganov BI
    Biokhimiia; 1994 Jun; 59(6):848-60. PubMed ID: 8075249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow step in activation of muscle glycogen phosphorylase b by adenosine 5'-monophosphate.
    Kurganov BI; Schors EI; Klinov SV; Chebotareva NA
    Biochem Mol Biol Int; 1995 May; 36(1):155-61. PubMed ID: 7663410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione-dependent reduction of arsenate by glycogen phosphorylase a reaction coupled to glycogenolysis.
    Németi B; Gregus Z
    Toxicol Sci; 2007 Nov; 100(1):36-43. PubMed ID: 17693425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme kinetics of muscle glycogen phosphorylase b.
    Walcott S; Lehman SL
    Biochemistry; 2007 Oct; 46(42):11957-68. PubMed ID: 17910419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deimination of glycogen phosphorylase b by peptidylarginine deiminase. Influence on the kinetical characteristics and dimer-tetramer transition.
    Eronina TB; Livanova NB; Chebotareva NA; Kurganov BI; Luo S; Graves DJ
    Biochimie; 1996; 78(4):253-8. PubMed ID: 8874800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of reductive alkylation on catalytic properties of glycogen phosphorylase B. enzyme derivatives with changed nucleotide affinities.
    Ho HC; Wirch E; Wang JH
    Biochim Biophys Acta; 1973 Aug; 317(2):462-72. PubMed ID: 19999728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interaction of muscle glycogen phosphorylase B with methotrexate, folic and folinic acids].
    Klinov SV; Chebotareva NA; Sheĭman BM; Birinberg EM; Kurganov BI
    Bioorg Khim; 1987 Jul; 13(7):908-14. PubMed ID: 3499906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
    Gregus Z; Németi B
    Toxicol Sci; 2007 Nov; 100(1):44-53. PubMed ID: 17693424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic mechanism of the glycogen-phosphorylase-catalysed reaction in the direction of glycogen synthesis: co-operative interactions of AMP and glucose 1-phosphate during catalysis.
    Sergienko EA; Srivastava DK
    Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):83-91. PubMed ID: 9359837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs.
    Oikonomakos NG; Kosmopoulou MN; Chrysina ED; Leonidas DD; Kostas ID; Wendt KU; Klabunde T; Defossa E
    Protein Sci; 2005 Jul; 14(7):1760-71. PubMed ID: 15987904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of specific deimination of glycogen phosphorylase b by peptidylarginine deiminase on the allosteric properties of the enzyme and dimer-tetramer transition].
    Eronina TB; Livanova NB; Chebotareva NA; Kurganov BI; Luo S; Graves DJ
    Mol Biol (Mosk); 1994; 28(6):1354-66. PubMed ID: 7885335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reconstruction of muscle glycogen phosphorylase b from an apoenzyme and pyridoxal-5'-phosphate and its analogs. Interaction of apophosphorylase and the reconstructed enzyme with specific ligands].
    Chebotareva NA; Sugrobova NP; Bulanova LN; Poznanskaia AA; Kurganov BI; Gunar VI
    Biokhimiia; 1995 Dec; 60(12):2030-9. PubMed ID: 8600997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of specific ligands on heat inactivation of muscle glycogen phosphorylase b].
    Kornilaev BA; Kurganov BI; Eronina TB; Livanova NB
    Biokhimiia; 1996 May; 61(5):871-9. PubMed ID: 8754272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of glycogen phosphorylase with 8-azidoadenosine 5'-monophosphate, a photoaffinity analog of AMP.
    Seery VL
    Biochim Biophys Acta; 1980 Mar; 612(1):195-204. PubMed ID: 6767498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analogous activation of bovine liver glycogen phosphorylase by AMP and IMP.
    Cámara-Artigas A; Parody-Morreale A; Barón C
    Int J Biochem Cell Biol; 1997 May; 29(5):849-56. PubMed ID: 9251252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FR258900, a potential anti-hyperglycemic drug, binds at the allosteric site of glycogen phosphorylase.
    Tiraidis C; Alexacou KM; Zographos SE; Leonidas DD; Gimisis T; Oikonomakos NG
    Protein Sci; 2007 Aug; 16(8):1773-82. PubMed ID: 17600143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.